DD 滴滴
@rtk17025
Full time BD for @o1_exchange
Cofounder of @GMWallet
Trade US HK stocks on @StableStock : DDD66
Best debit card @Backpack : backpack6666
Open for collabs 🦅🦅
2.5K Following 43.2K Followers
Why Stockcoin might be one of the most underrated global trading platforms right now.
U.S. stocks
Hong Kong stocks
Korean stocks
IPO & Pre-IPO access
AI-powered trading tools
Backed by Amber Group
10,000 USDT giveaway
official Invitation link :
Or you can use code : DDD666 in register page to get best fee rate
I broke down in this 1-minute Short 👇
Show more
We arrrrrre on the 🚀
The unrealized loss on 07709 Csop Leveraged And Inverse Series - Csop Sk Hynix Daily (2x) Leveraged Product ( 07709 )
yesterday was honestly brutal.
It dropped from 31 to almost 25 overnight, and with 3× leverage, the pressure was almost unbearable. I was genuinely in pain talking about it with @thecryptoskanda during the @Hertzflow_xyz AMA yesterday, but thankfully, I managed to hold through it.
And today, it surged to 40. What a turnaround.
Big thanks to Stablestock and @ZixiStablestock for lowest trading fee
Official referral link:
Referral code: DDD66
Show more
Just buy some 07709 on @StableStock
Ranging from 31.1-31.3
In 3x leverage
Crime buy
Bullish on $ARCANINE
0xf3715bf5c2de299f08b81180ffb739a8372a175f
Just like Bullish on 01810 Xiaomi
Arc Season is coming
@arc
🔥 Xiaomi (01810) is ripping +8% today
China szn is LIVE!
Trade 01810 Xiaomi on Stablestock with up to 6X leverage
✅ No KYC
✅ Deposit USDT
✅ Backed by YZI labs
Don’t sleep on this China moonshot 🚀
Official referral link:
Code: DDD66
#ChinaSzn# #Xiaomi# #01810#
Show more
Just buy some 07709 on @StableStock
Ranging from 31.1-31.3
In 3x leverage
Crime buy
Professional investors are quietly rotating. Retail is still asleep
While global headlines obsess over US mega-caps, Greater China just delivered one of the most explosive equity events of 2026:
CXMT (ChangXin Memory / 长鑫存储)
– Asia’s largest IPO this year: raised US$8.6 billion
– Debuted on Shanghai STAR Market
– +465% to +500% on day one
– Instantly became China’s most valuable listed company
– Market cap pushed past US$480–540 billion
– World’s 4th-largest DRAM maker, pure AI-server memory play
– Homegrown semiconductor self-sufficiency thesis fully validated
Market backdrop (as of 28 July 2026):
– Hang Seng Index closed 25,311, up +10% in the past month (recovered sharply from the June low of 22,518)
– Foreign holdings of onshore A-shares have already exceeded 4 trillion yuan
– China’s industrial profits +18.7% in H1 2026, led by high-tech & AI equipment
Names moving right now in Hong Kong:
– Horizon Robotics: +8.9%
– Xiaomi: +2.0%
– Tencent: +1.0%
– Meituan: +0.9–1.1%
– Lenovo & SMIC also seeing sustained AI-related bids
Shein is next in the pipeline (targeting US$40–50 billion valuation for its Hong Kong listing)
This is classic late-stage FOMO setup:
Massive primary market absorption + secondary market recovery + policy-backed AI/chip theme + real foreign capital inflows.
The smart money has already started positioning.
The ones still waiting for “confirmation” will be the ones explaining their underperformance in Q4.
Still on the sidelines?
Capital doesn’t wait for perfect narratives.
#ChinaEquities# #AShares# #HangSeng# #CXMT# #AIChips# #Semiconductor# #FOMO#
Show more
I called it a month ago — and now China season is finally here.
If you want to catch this wave without bleeding money on expensive Perps funding fees, buying China-related assets on Stablestock Spot is easily the smarter and more comfortable move.
No funding fees. No liquidation pressure. Just pure spot exposure to one of the hottest narratives in the market.
Don’t wait until everyone starts talking about it.
It’s China season.
Official referral link:
Official referral code: DDD66
Show more
I called it a month ago — and now China season is finally here.
If you want to catch this wave without bleeding money on expensive Perps funding fees, buying China-related assets on Stablestock Spot is easily the smarter and more comfortable move.
No funding fees. No liquidation pressure. Just pure spot exposure to one of the hottest narratives in the market.
Don’t wait until everyone starts talking about it.
It’s China season.
Official referral link:
Official referral code: DDD66
Show more
Now you can pairing stocks on O1
Snoo is the mascot for Reddit
0x8dfb7090971b0ba6c9c3ea004d98e7587f169201
Stockdog
0x4609540a90b1b3bff866a1ce893b0c8538432001
Join the new trench on O1
Show more
DeFi Just Made Hong Kong IPOs Accessible: Join Zhongji Xuchuang with Only 100 USDT
Hong Kong stock IPO subscription, commonly known as “打新”, is the practice of applying for shares at the offering price before a company officially lists. If you receive an allocation and the stock rises after listing, you can profit from the price difference. However, if it falls below the offering price, losses are possible. It has long been considered one of the more exciting short-term opportunities in the Hong Kong market, but it traditionally required significant capital and came with uncertainty around allotment rates.
This time, the spotlight is on Zhongji Xuchuang (03308), a global leader in high-speed optical modules used in AI data centers.
As AI models grow larger, the need for faster, lower-latency data transmission between GPUs has surged. Zhongji Xuchuang has been the world’s top optical interconnect solution provider by revenue for five consecutive years since 2021, holding roughly 21.2% of the global market and 28.1% of the high-speed data communication segment in 2025. The company is particularly strong in 400G, 800G, and 1.6T optical modules, making it a direct beneficiary of the ongoing AI infrastructure boom.
IPO Timeline and Details
Subscription period: July 22 to July 26, 2026 (closes at 3:00 PM Hong Kong time)
Allotment results: July 29, 2026
Listing date: July 30, 2026
Offering price: HK$1,010 per share
Lot size: 50 shares (approximately HK$50,500 per lot, or around HK$51,009 including fees)
The company plans to raise roughly HK$54.5 billion, with proceeds mainly allocated to R&D, capacity expansion, supply chain improvements, and strategic investments.
Two Ways to Participate
Traditionally, investors had to apply directly through a brokerage, which meant preparing enough capital for at least one full lot. This created a high barrier for many retail investors. Now, there is a more flexible alternative through IPO Earn, a DeFi-style product that allows participation with much smaller amounts.
With direct subscription, you apply for the shares yourself. You have full control over how many lots you apply for and what you do with the shares after listing. The downside is the relatively high capital requirement and the risk of not getting any allocation.
IPO Earn works differently. You subscribe using USDT (minimum 100 USDT), which is converted 1:1 into USDS. The product then uses these funds to participate in selected Hong Kong IPOs through a unified strategy. After confirmation, your funds are locked for 30 days. Returns are not fixed interest but come from the actual profit or loss of the IPO participations, reflected in the product’s net asset value. A 15% performance fee applies only when the strategy generates positive returns.
In short, direct subscription gives you more control but requires more capital and effort. IPO Earn lowers the entry barrier significantly and handles everything through a managed strategy, though it comes with a lock-up period and performance fees.
How to Join Zhongji Xuchuang IPO via IPO Earn
If you want to participate with a smaller amount, you can use the IPO Earn product on the Stockcoin platform. Registration is straightforward through this official link:
( official Invitation code: DD6666)
After registering and completing verification, simply go to the new share subscription section, find Zhongji Xuchuang (03308), and choose the IPO Earn option. The subscription deadline is July 26 at 3:00 PM Hong Kong time, so it’s best to complete everything a day or two earlier to avoid any last-minute issues.
Zhongji Xuchuang clearly benefits from the strong structural demand in AI data centers. At the same time, investors should still carefully consider the offering valuation, expected allotment rate, and overall market sentiment before participating.
Hong Kong IPO subscription has never been risk-free. New shares can trade below the offering price, and products like IPO Earn do not guarantee returns. This article is for informational purposes only and does not constitute investment advice. Always read the prospectus, product terms, and risk disclosures carefully before making any decisions.
Show more
< A guide Hong Kong IPO Subscription (港股打新) On-Chain >
The way that you can get 15x overnight
1. What is Hong Kong IPO Subscription (港股打新)?
港股打新 (Hong Kong IPO Subscription) refers to the process where retail (individual) investors apply to buy shares of a private company right before it officially lists and begins trading on the Hong Kong Stock Exchange (HKEX). This event is called an Initial Public Offering (IPO).
It is a highly popular short-term trading strategy because investors hope the stock price will experience a "pop" (a sudden surge in price) on its very first day of public trading due to hype and demand.
2. Current Hong Kong IPO Subscription Targets
As of early July 2026, several Hong Kong IPOs are open for subscription, but the three names worth focusing on here are EKH / Yongkang Holdings, Befar Group, and Nexchip Semiconductor. These three represent different themes: logistics, chemicals, and semiconductors.
EKH Limited / Yongkang Holdings —
EKH, also known by its Chinese name Yongkang Holdings, is a Singapore-based container depot and logistics operator. Its business includes container storage, handling, repair and maintenance, inspection, transportation, warehousing, container freight station services, and freight forwarding.
The company positions itself as the largest container depot operator in Singapore and the second largest in Southeast Asia by 2025 container throughput. This gives it exposure to Singapore’s role as a global shipping and transshipment hub. Its IPO price range is HK$2.20 to HK$2.68 per share, with 2,000 shares per board lot. The Hong Kong public offering runs from 30 June to 8 July 2026, and listing is expected on 13 July 2026 under stock code 02523.
The investment logic is relatively defensive. Logistics and container depot services are less “hot” than AI or semiconductors, but they benefit from recurring demand from shipping lines and container leasing companies. The main risks are competition, shipping-cycle volatility, and limited post-listing liquidity due to its smaller scale.
Befar Group / Binhua Group —
Befar Group, also known as Binhua Group, is a Chinese integrated chemical company founded in 1968. Its core businesses include chlor-alkali chemicals, C3/C4 chemicals, and wet electronic chemicals. Key products include sodium hydroxide, propylene oxide, MTBE, electronic-grade hydrofluoric acid, trichloroethylene, perchloroethylene, and allyl chloride.
According to available IPO information, the company is China’s largest producer of trichloroethylene, perchloroethylene, and allyl chloride by 2025 revenue, and one of the leading producers of propylene oxide and MTBE. This makes it a traditional chemical company with some exposure to higher-value electronic chemicals used in semiconductor and microelectronics manufacturing.
Its IPO price range is HK$3.05 to HK$3.59 per share, with 1,000 shares per board lot. The minimum entry amount is around HK$3,626.21. The subscription period runs from 30 June to 7 July 2026, and listing is expected on 10 July 2026 under stock code 06745. The company plans to offer about 352 million H shares, with around 10% allocated to the Hong Kong public offering and 90% to the international offering.
The investment logic is based on established market position, vertical integration, and exposure to electronic chemicals. The main risks are chemical-cycle volatility, environmental regulation, raw material and energy cost fluctuations, and the fact that this is a secondary listing of an existing A-share company.
Nexchip Semiconductor / Jinghe Integrated Circuit —
Nexchip Semiconductor, also known as Jinghe Integrated Circuit, is a leading Chinese 12-inch wafer foundry. It provides contract manufacturing services across mature and mid-range process nodes, including technologies from 150nm down to 40nm, and has also developed a 28nm logic platform.
The company benefits from China’s semiconductor localization trend, especially in mature-node chips used in display drivers, power management, automotive electronics, consumer electronics, AI-related hardware, IoT, and industrial control. It is already listed on the Shanghai STAR Market, so the Hong Kong IPO is an H-share secondary listing.
Nexchip is offering around 216.2 million shares, with the maximum offer price at HK$32.30 per share. Trading of its H shares is expected to begin on 10 July 2026. Reuters reported that the company aims to raise up to about HK$6.98 billion, and around 53.6% of the proceeds are expected to be used for R&D and optimization of its 22nm technology platform.
The investment thesis is stronger in terms of market theme because semiconductors remain one of the hottest sectors in Hong Kong IPOs. However, the risks are also higher. Nexchip faces competition from SMIC, Hua Hong, and global foundries, while semiconductor companies usually require heavy capital expenditure. Geopolitical restrictions and industry cyclicality are also important risks to consider.
3. How Can I Join Hong Kong IPOs or Trade Hong Kong Stocks On-Chain?
If you want to participate in Hong Kong pre-IPO or IPO subscriptions, you can use @stockcoinai
Register through this link:
Or enter the referral code manually:
DD6666
Current fee structure:
Spot subscription fee: HKD 50
Margin financing fee: HKD 90
KYC is simple and does not require proof of address.
If you want to trade Hong Kong stocks on-chain, you can use @StableStock .
Register through this link:
Or enter the referral code manually:
DDD66
StockCoins is more suitable for users who want to participate in Hong Kong IPO subscriptions, while StableStocks is more suitable for users who want to trade Hong Kong stocks directly on-chain.
Show more
GN🌳
Dev Buy,Dev Buy,Dev Buy
When you buy ? Got ıt.
$HAYLORD 🌳 @rtk17025
China’s AI Powerhouses: From Kimi’s Rocket Valuation to Hong Kong-Listed Plays —
What Wall Street’s Top Banks Are Saying
Kimi’s latest model, K3, has climbed to the top of several key benchmarks this month.
The 2.8-trillion-parameter open-weight system from Moonshot AI now matches or beats leading closed models from OpenAI and Anthropic on coding and long-context tasks.
That breakthrough has drawn fresh attention to China’s generative AI race.
Moonshot, founded in 2023 by former Meta and Google researcher Yang Zhilin, built its name on the Kimi chatbot. The company moved fast: it released the trillion-parameter K2 series in 2025, then pushed K3 in July 2026 with a million-token context window and native multimodal support. Full weights are due out by late July. Early users and independent tests show strong results in agent workflows and complex coding.
Revenue has kept pace. Annual recurring revenue crossed $200 million in April, with API sales making up more than 70 percent. Growth came from both consumer subscriptions and enterprise deals. Investors noticed. After a $4.3 billion valuation at the end of 2025, Moonshot raised roughly $2 billion in May at over $20 billion post-money, led by Meituan’s venture arm. It has now pulled in nearly $4 billion in six months and is reportedly targeting a $30 billion valuation in the next round. Backers include Alibaba, Tencent, and China Mobile.
The company is still private but has floated the idea of a Hong Kong listing. Its story shows how quickly private capital and open-weight models can scale in China when compute constraints push teams toward efficiency.
Two Listed Peers in Hong Kong
Two close rivals have already gone public on the Hong Kong exchange, giving investors direct exposure.
MiniMax ( focuses on multimodal generation across text, image, video, and audio. Its latest open model, M3, handles a million-token context. The company listed in January 2026 and raised about $619 million. Shares surged on debut but later pulled back sharply. In July it announced plans to raise another $2 billion through new shares and convertible bonds to fund infrastructure and model work. Customer numbers have grown quickly on both the enterprise and consumer sides.
Zhipu AI ( known for its GLM models, listed around the same time. GLM-5.2, released and open-sourced earlier this year, ranks among the strongest open models globally, especially in coding and long-horizon tasks. Shares climbed fast after listing, briefly pushing market value above HK$1 trillion before moderating. In July the company raised roughly $4 billion in a share placement and is preparing a possible Shanghai STAR listing. Founder Tang Jie has signaled a long-term push toward advanced agents and AGI-level capabilities rather than quick monetization.
Both stocks have been volatile, typical for early-stage AI names. Zhipu has held up better on model momentum; MiniMax has faced more pressure from dilution and lock-up expirations.
Established Player and Broader Exposure
SenseTime ( offers a more mature route into the same theme. The company built its business on computer vision and has expanded into generative models through the SenseNova line. Revenue rose 33 percent last year, with generative AI contributing strongly. Analysts generally rate the stock a buy, seeing room for further gains as multimodal tools move into commercial use.
Hong Kong’s broader AI theme also includes exposure through Tencent, Alibaba, and chip names such as SMIC and Biren. Many of these groups have invested in or compete directly with the startups above.
What Wall Street Banks Are Saying
Major banks have started coverage and see clear differentiation among the players.
Goldman Sachs initiated on Zhipu with a target around HK$1,880 and picked Zhipu, DeepSeek, and ByteDance as its top Chinese model names. The bank is constructive on the full China AI value chain — power, chips, infrastructure, and models — noting that global funds remain underweight despite China’s roughly $4 trillion in related market value.
Bank of America started both Zhipu and MiniMax with Buy ratings (targets HK$1,250 and HK$500). It describes a “two-speed” global market: the U.S. leads on raw frontier performance while Chinese models win on cost and efficiency for high-volume work. BofA also flags big long-term spending on Chinese AI data centers.
JPMorgan has been the most bullish on Zhipu, raising its target multiple times to HK$2,000 and higher while keeping an Overweight rating. The bank argues the sector is moving into a “winner-takes-more” phase where the strongest open models convert wide distribution into better monetization. It has been more cautious on MiniMax.
Morgan Stanley has also lifted Zhipu targets. Other houses have issued Buys on MiniMax at times. Common threads across the reports: open weights are accelerating adoption, Chinese teams are optimizing around domestic chips, and enterprise demand is strong even as compute remains tight.
Investment Angles
Direct plays sit in the two pure-play listings. Zhipu currently carries the strongest bank support tied to its enterprise focus and open-model upside. MiniMax offers multimodal leverage but comes with more near-term share supply pressure. SenseTime gives a steadier, vision-heavy alternative with improving margins.
Indirect routes run through Tencent and Alibaba, both investors in several of these companies and developers of their own competing models. Infrastructure names add another layer for those wanting exposure to the compute build-out.
The bullish case rests on cost advantages, open-source momentum, and practical enterprise use cases. Chinese models are gaining traction on platforms outside China and in cost-sensitive markets. Continued model leadership from names like Kimi and GLM could drive further revenue growth.
Risks are straightforward:
Fierce competition inside China, repeated capital raises that dilute shareholders, high valuations, and ongoing limits on advanced chips. Execution on turning open models into sustained profits remains unproven at scale.
Show more
We accept the DEAL !
To show our sincerity, if we lose this bet, both of our official accounts @GMWallet and @GMWalletHK will change their profile pictures to the Bitget logo.
One bet, Double rewards
So, are you in ?
@bitget
Show more
China’s AI Powerhouses: From Kimi’s Rocket Valuation to Hong Kong-Listed Plays —
What Wall Street’s Top Banks Are Saying
Kimi’s latest model, K3, has climbed to the top of several key benchmarks this month.
The 2.8-trillion-parameter open-weight system from Moonshot AI now matches or beats leading closed models from OpenAI and Anthropic on coding and long-context tasks.
That breakthrough has drawn fresh attention to China’s generative AI race.
Moonshot, founded in 2023 by former Meta and Google researcher Yang Zhilin, built its name on the Kimi chatbot. The company moved fast: it released the trillion-parameter K2 series in 2025, then pushed K3 in July 2026 with a million-token context window and native multimodal support. Full weights are due out by late July. Early users and independent tests show strong results in agent workflows and complex coding.
Revenue has kept pace. Annual recurring revenue crossed $200 million in April, with API sales making up more than 70 percent. Growth came from both consumer subscriptions and enterprise deals. Investors noticed. After a $4.3 billion valuation at the end of 2025, Moonshot raised roughly $2 billion in May at over $20 billion post-money, led by Meituan’s venture arm. It has now pulled in nearly $4 billion in six months and is reportedly targeting a $30 billion valuation in the next round. Backers include Alibaba, Tencent, and China Mobile.
The company is still private but has floated the idea of a Hong Kong listing. Its story shows how quickly private capital and open-weight models can scale in China when compute constraints push teams toward efficiency.
Two Listed Peers in Hong Kong
Two close rivals have already gone public on the Hong Kong exchange, giving investors direct exposure.
MiniMax ( focuses on multimodal generation across text, image, video, and audio. Its latest open model, M3, handles a million-token context. The company listed in January 2026 and raised about $619 million. Shares surged on debut but later pulled back sharply. In July it announced plans to raise another $2 billion through new shares and convertible bonds to fund infrastructure and model work. Customer numbers have grown quickly on both the enterprise and consumer sides.
Zhipu AI ( known for its GLM models, listed around the same time. GLM-5.2, released and open-sourced earlier this year, ranks among the strongest open models globally, especially in coding and long-horizon tasks. Shares climbed fast after listing, briefly pushing market value above HK$1 trillion before moderating. In July the company raised roughly $4 billion in a share placement and is preparing a possible Shanghai STAR listing. Founder Tang Jie has signaled a long-term push toward advanced agents and AGI-level capabilities rather than quick monetization.
Both stocks have been volatile, typical for early-stage AI names. Zhipu has held up better on model momentum; MiniMax has faced more pressure from dilution and lock-up expirations.
Established Player and Broader Exposure
SenseTime ( offers a more mature route into the same theme. The company built its business on computer vision and has expanded into generative models through the SenseNova line. Revenue rose 33 percent last year, with generative AI contributing strongly. Analysts generally rate the stock a buy, seeing room for further gains as multimodal tools move into commercial use.
Hong Kong’s broader AI theme also includes exposure through Tencent, Alibaba, and chip names such as SMIC and Biren. Many of these groups have invested in or compete directly with the startups above.
What Wall Street Banks Are Saying
Major banks have started coverage and see clear differentiation among the players.
Goldman Sachs initiated on Zhipu with a target around HK$1,880 and picked Zhipu, DeepSeek, and ByteDance as its top Chinese model names. The bank is constructive on the full China AI value chain — power, chips, infrastructure, and models — noting that global funds remain underweight despite China’s roughly $4 trillion in related market value.
Bank of America started both Zhipu and MiniMax with Buy ratings (targets HK$1,250 and HK$500). It describes a “two-speed” global market: the U.S. leads on raw frontier performance while Chinese models win on cost and efficiency for high-volume work. BofA also flags big long-term spending on Chinese AI data centers.
JPMorgan has been the most bullish on Zhipu, raising its target multiple times to HK$2,000 and higher while keeping an Overweight rating. The bank argues the sector is moving into a “winner-takes-more” phase where the strongest open models convert wide distribution into better monetization. It has been more cautious on MiniMax.
Morgan Stanley has also lifted Zhipu targets. Other houses have issued Buys on MiniMax at times. Common threads across the reports: open weights are accelerating adoption, Chinese teams are optimizing around domestic chips, and enterprise demand is strong even as compute remains tight.
Investment Angles
Direct plays sit in the two pure-play listings. Zhipu currently carries the strongest bank support tied to its enterprise focus and open-model upside. MiniMax offers multimodal leverage but comes with more near-term share supply pressure. SenseTime gives a steadier, vision-heavy alternative with improving margins.
Indirect routes run through Tencent and Alibaba, both investors in several of these companies and developers of their own competing models. Infrastructure names add another layer for those wanting exposure to the compute build-out.
The bullish case rests on cost advantages, open-source momentum, and practical enterprise use cases. Chinese models are gaining traction on platforms outside China and in cost-sensitive markets. Continued model leadership from names like Kimi and GLM could drive further revenue growth.
Risks are straightforward:
Fierce competition inside China, repeated capital raises that dilute shareholders, high valuations, and ongoing limits on advanced chips. Execution on turning open models into sustained profits remains unproven at scale.
Show more
As of July 2026, three mid-cap Hong Kong stocks deserve closer attention for their exposure to structural growth themes
Leapmotor (
remains one of the more compelling emerging EV names, supported by accelerating deliveries, new model launches, improving economies of scale, and its strategic partnership with Stellantis, which provides access to international distribution, manufacturing expertise, and overseas expansion opportunities.
NIO (
continues to offer a differentiated premium-EV proposition through its battery-swapping network, Battery-as-a-Service model, and multi-brand product strategy. Its key re-rating drivers include new vehicle launches, stronger delivery growth, tighter cost control, and potential margin improvement.
Goldwind Science & Technology ( meanwhile, provides direct exposure to China’s wind-power expansion and the broader global energy transition. Growth in higher-capacity turbine sales, domestic installation demand, export opportunities, and overseas market penetration could support earnings growth.
Based on the analyst estimates provided, all three stocks currently carry constructive institutional views and meaningful potential upside. However, investors should also account for execution risk, pricing competition, policy changes, earnings volatility, and the higher risk profile typically associated with mid-cap growth stocks.
˚₊‧꒰ა ✦ ໒꒱ ‧₊˚
Backed by @yzilabs , MPCi, and @vertexventures , @StableStock is building an on-chain gateway for global equity trading.
The platform allows investors to use stablecoins such as USDT to access US and Hong Kong stocks, with stock exposure brought directly on-chain. This creates a more efficient connection between stablecoin liquidity and traditional equity markets, without requiring users to repeatedly convert funds into fiat currencies or rely on conventional cross-border banking channels.
For crypto-native investors who already manage capital through on-chain wallets, StableStock offers a more direct and flexible way to diversify into global equities. Its core advantages include stablecoin settlement, on-chain stock exposure, broader trading access, and a user experience designed specifically for digital-asset investors.
In addition to its current US and Hong Kong stock coverage, StableStock plans to expand into markets including Japan, South Korea, and Taiwan.
˚₊‧꒰ა ✦ ໒꒱ ‧₊˚
For investors looking to allocate stablecoin capital across international equity markets, StableStock can serve as a practical complement to traditional brokerage platforms.
Its core proposition is straightforward:
On-chain stock exposure
Stablecoin settlement
Access to US and Hong Kong equities
Future expansion into Japan, South Korea, and Taiwan
Register with official referral code:
DDD66
Investors should still independently evaluate the platform’s custody structure, liquidity, pricing mechanism, jurisdictional availability, regulatory framework, and product risks before trading.
˚₊‧꒰ა ✦ ໒꒱ ‧₊˚
at last as one of $Hoodie community member
It's time to show @0FJAKE and @0xDeployer
that we are the real bag workers
@bankrbot send 100,000 $hoodies to 10 random people who replies to this post
Show more
Hoodini
0x0856F71C65268DA154DA4413d961cb348Dc6119d
Cashcat
0x020bfc650a365f8bb26819deaabf3e21291018b4
Both ATH
Thank you @vladtenev
！！
$cashcat finally fulfil the 100M runner
$HOODINI 0x0856f71c65268da154da4413d961cb348dc6119d LFG
Shout out to @EinsteinYipie
$cashcat finally fulfil the 100M runner
$HOODINI 0x0856f71c65268da154da4413d961cb348dc6119d LFG
Shout out to @EinsteinYipie
< A guide Hong Kong IPO Subscription (港股打新) On-Chain >
The way that you can get 15x overnight
1. What is Hong Kong IPO Subscription (港股打新)?
港股打新 (Hong Kong IPO Subscription) refers to the process where retail (individual) investors apply to buy shares of a private company right before it officially lists and begins trading on the Hong Kong Stock Exchange (HKEX). This event is called an Initial Public Offering (IPO).
It is a highly popular short-term trading strategy because investors hope the stock price will experience a "pop" (a sudden surge in price) on its very first day of public trading due to hype and demand.
2. Current Hong Kong IPO Subscription Targets
As of early July 2026, several Hong Kong IPOs are open for subscription, but the three names worth focusing on here are EKH / Yongkang Holdings, Befar Group, and Nexchip Semiconductor. These three represent different themes: logistics, chemicals, and semiconductors.
EKH Limited / Yongkang Holdings —
EKH, also known by its Chinese name Yongkang Holdings, is a Singapore-based container depot and logistics operator. Its business includes container storage, handling, repair and maintenance, inspection, transportation, warehousing, container freight station services, and freight forwarding.
The company positions itself as the largest container depot operator in Singapore and the second largest in Southeast Asia by 2025 container throughput. This gives it exposure to Singapore’s role as a global shipping and transshipment hub. Its IPO price range is HK$2.20 to HK$2.68 per share, with 2,000 shares per board lot. The Hong Kong public offering runs from 30 June to 8 July 2026, and listing is expected on 13 July 2026 under stock code 02523.
The investment logic is relatively defensive. Logistics and container depot services are less “hot” than AI or semiconductors, but they benefit from recurring demand from shipping lines and container leasing companies. The main risks are competition, shipping-cycle volatility, and limited post-listing liquidity due to its smaller scale.
Befar Group / Binhua Group —
Befar Group, also known as Binhua Group, is a Chinese integrated chemical company founded in 1968. Its core businesses include chlor-alkali chemicals, C3/C4 chemicals, and wet electronic chemicals. Key products include sodium hydroxide, propylene oxide, MTBE, electronic-grade hydrofluoric acid, trichloroethylene, perchloroethylene, and allyl chloride.
According to available IPO information, the company is China’s largest producer of trichloroethylene, perchloroethylene, and allyl chloride by 2025 revenue, and one of the leading producers of propylene oxide and MTBE. This makes it a traditional chemical company with some exposure to higher-value electronic chemicals used in semiconductor and microelectronics manufacturing.
Its IPO price range is HK$3.05 to HK$3.59 per share, with 1,000 shares per board lot. The minimum entry amount is around HK$3,626.21. The subscription period runs from 30 June to 7 July 2026, and listing is expected on 10 July 2026 under stock code 06745. The company plans to offer about 352 million H shares, with around 10% allocated to the Hong Kong public offering and 90% to the international offering.
The investment logic is based on established market position, vertical integration, and exposure to electronic chemicals. The main risks are chemical-cycle volatility, environmental regulation, raw material and energy cost fluctuations, and the fact that this is a secondary listing of an existing A-share company.
Nexchip Semiconductor / Jinghe Integrated Circuit —
Nexchip Semiconductor, also known as Jinghe Integrated Circuit, is a leading Chinese 12-inch wafer foundry. It provides contract manufacturing services across mature and mid-range process nodes, including technologies from 150nm down to 40nm, and has also developed a 28nm logic platform.
The company benefits from China’s semiconductor localization trend, especially in mature-node chips used in display drivers, power management, automotive electronics, consumer electronics, AI-related hardware, IoT, and industrial control. It is already listed on the Shanghai STAR Market, so the Hong Kong IPO is an H-share secondary listing.
Nexchip is offering around 216.2 million shares, with the maximum offer price at HK$32.30 per share. Trading of its H shares is expected to begin on 10 July 2026. Reuters reported that the company aims to raise up to about HK$6.98 billion, and around 53.6% of the proceeds are expected to be used for R&D and optimization of its 22nm technology platform.
The investment thesis is stronger in terms of market theme because semiconductors remain one of the hottest sectors in Hong Kong IPOs. However, the risks are also higher. Nexchip faces competition from SMIC, Hua Hong, and global foundries, while semiconductor companies usually require heavy capital expenditure. Geopolitical restrictions and industry cyclicality are also important risks to consider.
3. How Can I Join Hong Kong IPOs or Trade Hong Kong Stocks On-Chain?
If you want to participate in Hong Kong pre-IPO or IPO subscriptions, you can use @stockcoinai
Register through this link:
Or enter the referral code manually:
DD6666
Current fee structure:
Spot subscription fee: HKD 50
Margin financing fee: HKD 90
KYC is simple and does not require proof of address.
If you want to trade Hong Kong stocks on-chain, you can use @StableStock .
Register through this link:
Or enter the referral code manually:
DDD66
StockCoins is more suitable for users who want to participate in Hong Kong IPO subscriptions, while StableStocks is more suitable for users who want to trade Hong Kong stocks directly on-chain.
Show more
Biotech, AI Mobility, and Chips Ignite Hong Kong’s Revaluation Trade
39% SURGE PUMPING STOCKS ARE BACK
The Hong Kong stock market has entered a highly active phase of technical reversion, representing a major rotation into deeply discounted growth vectors.
Backed by compressed geopolitical risk premiums and stronger-than-expected domestic industrial profit margins, institutional capital is aggressively accumulating risk-on assets. While the broader Hang Seng Index advanced 355 points to settle at 23,027, the underlying momentum was violently expressed in specific high-beta sectors, rapidly transitioning away from defensive posturing toward oversold growth accumulation.
Sector Rotation and Capital Flows
The market is structurally dividing into distinct recovery layers, each with varying institutional dynamics and investment barriers.
The biotechnology and healthcare complex carries the highest momentum right now. It includes clinical-stage innovators and artificial intelligence drug discovery platforms benefiting from extreme valuation arbitrage and record outbound licensing transactions.
Smart mobility and technology infrastructure involve manufacturers and AI data integrators capturing secular growth narratives. These firms focus on advanced driver assistance systems and vehicular artificial intelligence frameworks.
Leveraged derivative instruments and semiconductor equipment providers are amplifying these underlying spot price movements, reflecting aggressive momentum-driven tape reading among institutional trading desks anticipating a global silicon demand recovery.
The Biotechnology Renaissance
These companies are the visible face of the healthcare sector's aggressive mean reversion, capitalizing on trough valuations and robust clinical fundamentals.
TransThera-B (
Closed at 12.720, up 3.620 (+39.78%). Emerging as the premier beneficiary across the exchange, this clinical-stage biopharmaceutical company executed a staggering surge. Having endured a debilitating sixty percent capitulation in preceding sessions, this price action represented a textbook short-covering squeeze amplified by liquidity vacuums.
DualityBio-B (
Closed at 189.000, up 26.200 (+16.09%). Capitalizing on its recent inclusion in the HKEX TECH-100 Index, this entity mirrors the broader institutional accumulation flowing into antibody-drug conjugate pipelines and next-generation therapies.
XtalPi (
Closed at 7.740, up 0.990 (+14.67%). Operating at the highly coveted intersection of artificial intelligence and structural biology, its momentum remains firmly underpinned by a four hundred million dollar strategic partnership for a GPCR-targeted oral small-molecule program.
Other clinical-stage innovators symmetrically buoyed by this rising tide of liquidity include RemeGen ( closing at 79.700 (+14.43%), Keymed Bio-B ( closing at 73.100 (+14.13%), and CStone Pharma-B ( closing at 4.880 (+10.66%).
Here I strongly suggest reviewing recent institutional notes regarding the Chinese biotech sector's extreme oversold territory. The fundamental underpinning of this rally remains exceptionally robust, corroborated by record clinical trial expansions and validation at global oncology assemblies. The domestic clinical trial landscape expanded beyond five thousand active studies this year, triggering an immense influx of institutional capital.
Smart Mobility and Technology Infrastructure
These companies manufacture the critical hardware and data infrastructure that secular growth narratives rely on, capturing substantial capital inflows.
HorizonRobot-W (
Closed at 4.140, up 0.530 (+14.68%). Solidifying its market dominance in advanced driver assistance systems, the firm currently commands nearly half the domestic original equipment manufacturer market.
Top analysts at JPMorgan and Goldman Sachs frequently highlight Horizon Robotics as a critical supply chain player. JPMorgan pivots its overweight stance on the accelerated commercialization of the Horizon SuperDrive solutions. Goldman Sachs amplifies this bullish conviction, citing the pervasive integration of the Journey 6 systemic architecture across elite automotive platforms including Chery, SAIC, and Geely.
Xunce (
Closed at 119.400, up 16.400 (+15.92%). An artificial intelligence data infrastructure specialist that translated its post-initial public offering revenue milestones and strategic vehicular partnerships into formidable equity appreciation.
Axera (
Closed at 14.270, up 1.700 (+13.52%). A key player within the AI hardware ecosystem, moving in tandem with the broader technology infrastructure rotation and intelligent processing narratives.
Semiconductors and High-Beta Instruments
This segment reflects indirect accumulation strategies predicated on impending global demand recovery and aggressive institutional momentum trading.
ASMPT (
Closed at 217.000, up 21.900 (+11.23%). The directional movement of this semiconductor assembly provider validated the risk-on market architecture, anticipating a global silicon demand recovery and capital expenditure expansions.
GigaDevice 3X (
Closed at 1,241.000, up 158.000 (+14.59%). A leveraged derivative instrument that magnified underlying spot price volatility, reflecting extreme momentum-driven tape reading among institutional trading desks. Metis Techbio-P 2X ( exhibited similar derivative strength within the biotech space, closing at 14.600 (+11.88%).
General small-cap and digital technology equities further demonstrated this broader risk-on accumulation across various market capitalizations, with Tianli Holdings ( closing at 4.440 (+16.23%) and MOG Digitech ( closing at 0.083 (+10.67%).
Show more
$OUST is surging
WHO WILL BE THE NEXT
< China's Embodied AI and Robotics Sector >
After reading @crux_capital_ article, I was left pondering a more structural question:
If $OUST represents a certain kind of market mispricing in the U.S., then where might its Chinese counterpart be found?
For investors in Chinese equities, the answer may not lie in one company alone, but in the market’s deeper revaluation cycle.
1. Executive Summary
The Chinese Embodied Intelligence and humanoid robotics sector has entered a highly active phase, representing the next major application frontier following Generative AI.
Backed by a comprehensive industrial supply chain, strong policy support, and manufacturing cost efficiencies, Chinese firms are well-positioned in this space. While the industry is currently in the early stages of commercialization, it is rapidly transitioning toward mass production and proof of profitability across industrial, service, and household applications.
2. Industry Value Chain Analysis
The sector is structurally divided into four distinct layers, each with varying barriers to entry and investment dynamics.
Upstream components carry the highest technical barriers. It includes harmonic reducers, servo motors, actuators, sensors, and AI computing chips.
Midstream complete machines involve manufacturers of the actual robot bodies. These firms focus on integrating large models with motion control and multimodal perception.
Downstream applications include integrators deploying robots into specific environments, such as factory floors, smart homes, and research.
Supporting infrastructure covers developers of simulation software, world models, and national standards.
3. Key Players: Complete Systems and Platforms
These companies are the visible face of the industry, manufacturing the integrated robotic systems.
UBTech Robotics (
A leading global and domestic humanoid robot developer, widely recognized as the first humanoid robot stock listed in Hong Kong. The Walker series, specifically the industrial Walker S models, have already been deployed in real-world automotive manufacturing environments. In 2025, humanoid robots became the company's largest revenue driver, accounting for approximately 41% of total sales. The company emphasizes a full-stack approach, merging large AI models with advanced motion control, and boasts a leading order backlog and patent portfolio.
Woan Robotics / OneRobotics (
Listed in late 2025, it is positioned as China’s first AI embodied household robot stock. It focuses heavily on domestic scenarios, building upon its established SwitchBot smart home ecosystem. It utilizes a One Brain, Multiple Forms architecture, and over 95% of its revenue is generated overseas, driven by strong software-hardware co-evolution.
Unitree Robotics (Pre-IPO)
A globally recognized manufacturer of both quadruped and humanoid robots. As of June 2026, Unitree passed the STAR Market listing review in a record 73 days and is in the registration stage. It is highly anticipated to become the A-share market's first general-purpose Embodied AI stock.
Here I strongly suggest @shanaka86 article
Shanaka thread is better than many Chinese analysts I’ve read.
“You can now buy a humanoid robot for 4,900 dollars. ... The robot is Unitree's R1, out of China ... Tesla's Optimus is not for sale at any price ... Unitree already shipped more than 5,500 humanoids last year and grew revenue 335 percent. The West is still perfecting the robot. China is already selling it on AliExpress.
... The body costs 4,900 dollars. The mind and the hands are still priceless...”
top analysts @ZacksJerryRig and @RnaudBertrand also mentioned Unitree at
4. Key Players: Upstream Chokepoint Components
These companies manufacture the critical hardware infrastructure that robotic systems rely on. This segment is highly favored by supply chain analysts because these companies benefit from the growth of the entire sector, regardless of which specific robot brand wins market share.
RoboSense (
A leading Chinese manufacturer of advanced perception systems. Frequently highlighted as a critical supply chain player in reports by Goldman Sachs, Morgan Stanley, and Bank of America. Its high-performance radar and perception systems are critical for humanoid robots to achieve autonomous navigation, environmental mapping, and complex obstacle avoidance.
Leader Harmonic Drive (
China’s dominant manufacturer of precision harmonic reducers, holding over 60% of the domestic market share. These components are heavily relied upon for joint mobility. Because the technology has extremely high barriers to entry and is difficult to substitute, it represents a major portion of a robot's Bill of Materials cost.
@aleabitoreddit discusses the convergence of robotics and the automotive supply chain, using Schaeffler as a case study. It highlights the high BOM exposure of humanoid robots and connects this with China’s structural advantage in low-cost, large-scale manufacturing.
Other Notable Supply Chain Beneficiaries include Inovance, Estun, Shuanghuan Transmission, and Lingyun Guang.
5. Analyst Perspective
Morgan Stanley has repeatedly upgraded its China humanoid robot forecasts. In mid-2026, it raised its 2026 shipment projection to 50,000 units (nearly double its prior estimate of 28,000 and significantly higher than the original January forecast of 14,000).
It projects the Chinese humanoid market reaching ~$2 billion in 2026 and growing to ~$15 billion by 2030.
The bank highlights faster-than-expected commercialization, strong policy support, and accelerating supply-chain momentum. These reports are widely referenced on X when discussing UBTech, Unitree, and Chinese supply chain plays.
Goldman Sachs has specifically flagged Leader Harmonic Drive ( in research for its high technological barriers (harmonic reduction gears) and potential to capture significant component value in humanoid robots. The firm has noted the company’s strong positioning in high-barrier parts that represent a meaningful portion of humanoid BOM (bill of materials) costs.
Investments focus on hard-to-replace components with high BOM shares. These companies provide the shovels during a gold rush, benefiting from aggregate industry volume growth driven by China's low-cost, large-scale manufacturing edge. Some system-level companies are also viewed favorably within this framework due to their unique, hard-to-replicate software-hardware synergy in niche environments.
6. Investment Outlook and Risk Assessment
Catalysts and opportunities include aggressive state promotion of robotics implementation, rapid iteration in both hardware cost-reduction and software capabilities, and an imminent transition from R&D to mass volume production.
Inherent risks stem from the early commercialization phase, as many market entrants are still restricted to R&D or small-batch production. High market attention has led to elevated multiples across the sector, resulting in sharp price volatility. Geopolitical tensions and international trade competition could also impact overseas revenue streams.
The Chinese embodied robotics sector offers high growth potential but carries equivalent volatility.
A diversified approach, balancing high-potential complete-machine manufacturers with entrenched, high-barrier upstream component suppliers, is the most sound strategy for navigating this emerging AI wave.
Show more
